Recent nutritional research in very-low-birth-weight (VLBW) infants is focused on the prevention of protein malnutrition during the first postnatal weeks. At this early age, nutritional protein fortification depends on amino acid infusion via a central vein because of the immature gastrointestinal tract. In 2010 new guidelines on nutrition were proposed by the European Society of Paediatric Gastroenterology, Hepatology, and Nutrition nutrition committee. In particular, the relative increase in the protein fraction in the nutrition of these infants aims to prevent early postnatal weight loss, to prevent morbidity, and to stimulate neurodevelopment. On the other hand, an increasing number of follow-up studies in VLBW infants indicate that, in particular, those infants who show rapid growth after preterm birth are at risk of metabolic consequences and cardiovascular disease later in life. In this review, we describe the quest to develop a customized diet that offers optimal nutrition at several time points of growth and development during the first year of life. This diet should prevent early malnutrition, enhance neurodevelopment, and limit the increase in total body fat during the first 6 mo. We question whether one type of early diet suffices for normal neurodevelopment with a normal body composition in later life or whether we need several types of diet at various stages of development.
INTRODUCTION
Fetal growth is characterized by the interaction of the fetal genome and its environment. The fetal environment, in turn, is influenced by the mother's environment and metabolism and by the placenta. Intrauterine growth is regulated by genetic factors, essential substrates, and endocrine factors. In utero, important growth regulatory hormones are insulin and thyroxin and insulin-like growth factors that are regulated independently of growth hormone. After birth, the regulation of insulin-like growth factors becomes increasingly more growth hormone dependent. It is suggested that growth regulation may be permanently altered-ie, programmed-in utero and even during infancy. By changes in the nutritional, hormonal, and/or metabolic factors afforded by the mother during critical periods of development, reprogramming exerts lasting or lifelong changes in the structure and physiology of her offspring. Examples of mechanisms that are based on such programming are changes in gene expression, reduction in cell numbers, imbalance between cell types, changes in organ structure, and changes in the secretion and sensitivity of hormones. Comparable mechanisms are suggested from the long-term observational studies of the Dutch famine that described the onset of type 2 diabetes at a later age in the offspring of mothers who were malnourished during the winter of 1944-1945 (1) . Low birth weight, as a proxy of intrauterine growth retardation, is associated with chronic diseases in adulthood such as hypertension, cardiovascular disease, insulin resistance, and type 2 diabetes (2). In particular, the third trimester of pregnancy is considered to be a critical phase for the programming of body functions. A shortage of nutrients during the third trimester followed by an abundance of nutrients thereafter favors catch-up growth, and it is suggested that this is related to cardiovascular disease (3) and insulin resistance (4) .
Furthermore, previous studies showed that rapid growth during the first 3 mo of life may promote obesity (5), increased blood pressure (6, 7), insulin resistance, and cardiovascular disease in term-born adults (8, 9) . The development of long-term metabolic consequences may be related to fat accumulation during an early postnatal window (10) . In preterm-born adults, a long-term follow-up study in 1983 in The Netherlands [Project on Preterm and Small for Gestational Age birth (POPS cohort)] showed that increased weight gain between birth and age 3 mo and, to a lesser extent, increased weight gain between ages 3 and 12 mo are associated with a higher percentage body fat and more abdominal fat at age 19 y (11) . From these observations it may be suggested that nutritional interventions in very-low-birth-weight (VLBW) infants (,1500 g) are possible only if they are timed within a critical window of programming after birth.
THE IMPORTANCE OF IMMEDIATE POSTNATAL NU-TRITION IN PRETERM VLBW INFANTS
Increased survival of VLBW infants, who often weigh ,600-700 g at the gestational ages of 24-26 wk, was observed after the introduction of total parenteral nutrition (TPN) in these extremely small infants. In general, during the first 2 postnatal weeks, these infants can be fed only small amounts of oral nutrition, preferably the mother's own breast milk, because of the immaturity of the gut system. An aggressive increase in oral feeding may lead to necrotizing enterocolitis. Because it was not clear which parenteral nutrition composition would be the most optimal for these infants, protein addition to the TPN was often postponed for 3 d or even for 1 wk. Many reports have warned of the development of uremia, in particular in small-for-gestationalage infants fed with high amounts of amino acids. Others advocated that with the correct amino acid composition of TPN the postnatal growth restriction of these infants could be prevented (12, 13) . Several studies showed that low amounts of protein during the first postnatal weeks led to severe extrauterine growth restriction (14) (15) (16) . This postnatal growth restriction in VLBW infants has been associated with decreased brain growth and an unfavorable neurodevelopmental outcome (17, 18) . and showed a relation between poor growth and a higher incidence of a motor developmental index ,70, a physical developmental index ,70, cerebral palsy, and impaired neurodevelopment. These findings do not show a direct relation between neurodevelopment and growth; they only show that with poor postnatal growth the risk of poor neurodevelopment increases (18) . In particular, stable-isotope studies in VLBW infants showed that with improved amino acid compositions as part of TPN, better (26) by using the most recent ESPGHAN guidelines (24) . Data on protein intake from our neonatal intensive care unit were obtained from 133 preterm infants at week 1, 125 preterm infants at week 2, 124 preterm infants at week 3, and 122 preterm infants at week 4. Senterre and Rigo's study included 84 preterm infants. ESPGHAN, European Society of Paediatric Gastroenterology, Hepatology, and Nutrition. growth may be observed without uremia or hyperammonemia (19, 20) . With the help of stable-isotope technology, in preterm infants the fetal turnover of amino acids in vivo may be observed near term age (21). All amino acid turnover studies showed a high protein turnover of 5-7 g$ kg 21 $ d 21 in the placental to fetal circulation, leading to a protein gain in the fetus of
. Some nonessential amino acids (eg, glutamine) are preferentially absorbed by VLBW infants and are therefore considered semiessential to these infants (22) . Recently, it was shown that the immediate addition of postnatal glutamine to the nutrition of VLBW infants has a positive effect on cognitive development at 7 y of age (23) . For this reason, an expert group, together with the members of the European Society of Paediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) nutrition committee, has recently updated the guidelines for nutritional requirements of VLBW infants to conform with the most recent research (24) .
With one of these new TPN mixtures containing relatively high protein as advised by the ESPGHAN for VLBW infants, Rigo et al (25) achieved better postnatal growth in a group of preterm infants immediately after birth. Furthermore, Senterre and Rigo (26, 27) showed that by using this approach the cumulative protein loss as described by Embleton et al (14) may be prevented. During the first postnatal weeks, higher protein intakes were achieved by Senterre and Rigo as compared with standard practice at our neonatal intensive care unit (Figure 2 ) and hence postnatal extrauterine growth restriction was reduced (26) . At present in most neonatal intensive care unit centers, VLBW infants are preferably fed with their mothers' own milk. Since the introduction of bedside breast-milk protein analyzers, the prescription of breast-milk fortifiers may be individualized, and even in preterm infants who are fed with their mothers' own milk, the immediate weight loss that occurs postnatally as a result of a low protein intake may be prevented. 
TIMING OF NUTRITIONAL INTERVENTIONS IN VLBW INFANTS

IS THERE A ROLE FOR POSTDISCHARGE NUTRITION?
Approximately 20 y ago, Lucas et al (28) introduced the concept of postdischarge nutrition for preterm infants after observing the rapid decline in growth velocity when preterm infants were discharged with nutrition that was equal to that given to term infants. The postdischarge nutrition was a mixture of special preterm formula and regular term formula and resulted in better bone development in preterm infants compared with term formula (29) . A large trial with postdischarge nutrition in preterm infants was conducted by Cooke et al (30) in 1998. The difference from the postdischarge intervention by Lucas et al was the composition of the postdischarge formula: Cooke et al suggested to prescribe the special preterm formula containing high energy and high protein until 6 mo corrected age (30) (31) (32) . Since then, many studies have been published that used different formula compositions, a variety of intervention durations, and a variety of cohorts. Fifteen trials on postdischarge nutrition including 1128 preterm infants were compared in a Cochrane meta-analysis (33, 34) . Unfortunately, 9 valuable studies were excluded from this meta-analysis because the Cochrane analyzers misinterpreted the composition of the diet or judged the diet as inappropriate for no clear reasons (34) (35) (36) (37) (38) . As may be predicted because of the variety of diets and the rather small cohorts studied, the meta-analysis showed no clear benefit of postdischarge nutrition. However, one specific observation was common in most of these studies: postdischarge nutrition was beneficial in boys but not in girls (33) . As observed in Table 1 , most studies could not be compared properly as a result of the variety and timing of diets and outcome variables (35) (36) (37) (39) (40) (41) (42) (43) (44) (45) . Nevertheless, in 2006, the ESPGHAN nutrition committee decided to advise the use of postdischarge nutrition until at least 40-52 wk postconceptional age (46) . Amesz et al (38) and van de Lagemaat et al (47) (48) (49) published the results of a postdischarge nutrition study in 2010, 2012, and 2013 that used a postdischarge formula that was equal in energy (67 kcal/100 mL formula) but relatively higher in protein and arachidonic acid composition as compared with regular term formula. As a reference, human-milk-fed infants were included. In this study, no differences were observed in growth variables. However, significant differences were found in fat mass gain between infants fed regular term formula and normal-energy/high-protein postdischarge formula and in bone mineral density between infants fed human milk and formula, with a particular benefit for boys but with less effects in girls ( Table 2) . It is remarkable that a formula with normal energy but a relatively large proportion of protein results in a body composition with a significantly lower percentage of body fat at 6 mo corrected age. This observation is in contrast with the observation at 4 mo corrected age in the study of Picaud et al (45) that used a high energy/high protein diet ( Table 3 ). This beneficial finding may imply that catch-up growth with a normal-energy/high-protein postdischarge formula is limited in fat deposition, which might result in a lower risk to develop metabolic syndrome later on. Long-term followup studies investigating body composition at 7 y of age are now in progress.
CONCLUSIONS
In VLBW preterm infants the most optimal nutritional intervention, which optimizes growth and brain development, is immediate postnatal high-protein nutrition. This can be obtained by innovative TPN and individualized fortified human breast milk to limit extrauterine growth restriction and to prevent the need for exaggerated post-term catch-up growth. This may reduce the risk of adverse metabolic consequences later in life. Meanwhile, as long as extrauterine growth restriction cannot yet be successfully prevented in some VLBW infants, postdischarge nutrition given by a formula that is normal in energy but high in protein may result in a normal body composition and consequently may lower the risk of the development of metabolic syndrome later in life.
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